Robertson Opportunity Capital Has Boosted Mgic Invt Wis (MTG) Holding By $2.09 Million; Caredx (CDNA) Shorts Lowered By 5.26%

December 7, 2017 - By Marie Mckinney

Robertson Opportunity Capital Llc increased Mgic Invt Corp Wis (MTG) stake by 65.97% reported in 2017Q2 SEC filing. Robertson Opportunity Capital Llc acquired 190,000 shares as Mgic Invt Corp Wis (MTG)’s stock declined 1.12%. The Robertson Opportunity Capital Llc holds 478,000 shares with $5.35 million value, up from 288,000 last quarter. Mgic Invt Corp Wis now has $5.72 billion valuation. The stock decreased 0.10% or $0.01 during the last trading session, reaching $15.44. About 40,046 shares traded. MGIC Investment Corporation (NYSE:MTG) has risen 60.12% since December 7, 2016 and is uptrending. It has outperformed by 43.42% the S&P500.

Caredx Incorporated (NASDAQ:CDNA) had a decrease of 5.26% in short interest. CDNA’s SI was 2.73M shares in December as released by FINRA. Its down 5.26% from 2.88 million shares previously. With 200,000 avg volume, 14 days are for Caredx Incorporated (NASDAQ:CDNA)’s short sellers to cover CDNA’s short positions. The SI to Caredx Incorporated’s float is 18.25%. The stock increased 0.32% or $0.02 during the last trading session, reaching $6.34. About 802 shares traded. CareDx, Inc (NASDAQ:CDNA) has declined 74.10% since December 7, 2016 and is downtrending. It has underperformed by 90.80% the S&P500.

CareDx, Inc., together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company has market cap of $181.35 million. The firm operates through two divisions, CareDx and Olerup. It currently has negative earnings. The Company’s commercialized testing solution includes the AlloMap heart transplant molecular test , a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection.

Among 5 analysts covering CareDx (NASDAQ:CDNA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CareDx had 8 analyst reports since September 25, 2015 according to SRatingsIntel. The stock of CareDx, Inc (NASDAQ:CDNA) earned “Buy” rating by Mizuho on Tuesday, June 14. The firm has “Buy” rating given on Friday, September 25 by Craig Hallum. The firm has “Market Perform” rating given on Monday, September 28 by Raymond James. Raymond James upgraded CareDx, Inc (NASDAQ:CDNA) on Wednesday, September 27 to “Outperform” rating. The firm has “Buy” rating by Craig Hallum given on Monday, October 9. Piper Jaffray maintained the shares of CDNA in report on Sunday, September 24 with “Buy” rating.

Investors sentiment decreased to 0.73 in Q2 2017. Its down 0.49, from 1.22 in 2017Q1. It dropped, as 6 investors sold CareDx, Inc shares while 5 reduced holdings. 2 funds opened positions while 6 raised stakes. 6.38 million shares or 18.44% less from 7.82 million shares in 2017Q1 were reported. Gagnon Secs Limited Liability Corporation owns 2.08 million shares. Tpg Gp (Sbs) Advisors Inc invested 0% in CareDx, Inc (NASDAQ:CDNA). California Public Employees Retirement Systems reported 175,000 shares stake. Northern, Illinois-based fund reported 14,089 shares. Geode Limited Liability invested in 43,139 shares. Morgan Stanley accumulated 1,039 shares. Panagora Asset Mngmt Incorporated reported 52,054 shares. Vanguard Gp stated it has 248,084 shares. 10,000 were accumulated by Teton Advisors. Barclays Public Limited Company stated it has 0% of its portfolio in CareDx, Inc (NASDAQ:CDNA). Goldman Sachs has invested 0% in CareDx, Inc (NASDAQ:CDNA). 3,911 are owned by Tower Research Capital Ltd Co (Trc). 6,000 were reported by Thompson Davis Company Inc. Gagnon Advsrs Lc holds 0.91% of its portfolio in CareDx, Inc (NASDAQ:CDNA) for 954,272 shares. Private Wealth Limited Liability owns 0% invested in CareDx, Inc (NASDAQ:CDNA) for 10,000 shares.

Investors sentiment decreased to 1.08 in Q2 2017. Its down 0.14, from 1.22 in 2017Q1. It dived, as 34 investors sold MTG shares while 85 reduced holdings. 36 funds opened positions while 93 raised stakes. 321.13 million shares or 5.08% more from 305.62 million shares in 2017Q1 were reported. 133,300 are held by Virginia Retirement Et Al. Federated Investors Pa invested in 211,217 shares. Oskie Cap Ltd Liability reported 142,362 shares. Pdts Prtn Ltd Liability Corp holds 0.36% of its portfolio in MGIC Investment Corporation (NYSE:MTG) for 807,096 shares. Arrowstreet Capital Partnership reported 11,800 shares stake. Moreover, Moore Cap Lp has 0.41% invested in MGIC Investment Corporation (NYSE:MTG). New York State Teachers Retirement Sys holds 29,900 shares. Guggenheim Cap Ltd holds 0% or 70,139 shares in its portfolio. Deutsche National Bank Ag reported 3.12M shares or 0.02% of all its holdings. Invesco has invested 0.02% in MGIC Investment Corporation (NYSE:MTG). Two Sigma Secs Ltd Liability has 0.04% invested in MGIC Investment Corporation (NYSE:MTG). Geode Mngmt Limited Company owns 2.91 million shares. 1.27 million are owned by Oaktree Cap Management L P. Automobile Association holds 820,400 shares. Point72 Asset Mgmt LP holds 1.75M shares or 0.11% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: